Impact Capital Partners LLC
Source: SEC Form 13F · as of Mar 2026Impact Capital Partners LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $23.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$23.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 25,157 | $6.1M |
| ABBVAbbVie Inc. | 22,260 | $4.8M |
| ABTABBOTT LABORATORIES | 23,311 | $2.4M |
| LLYELI LILLY & Co | 2,223 | $2.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,591 | $1.8M |
| MRKMerck & Co., Inc. | 11,577 | $1.4M |
| PMPhilip Morris International Inc | 8,268 | $1.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,163 | $966K |
| PFEPFIZER INC | 12,726 | $357K |
| AZNASTRAZENECA PLC | 1,756 | $346K |
| AMGNAMGEN INC | 848 | $298K |
| MCKMcKesson Corporation | 335 | $290K |
| BMYBRISTOL MYERS SQUIBB CO | 4,610 | $280K |
| CAHCardinal Health Inc. | 1,280 | $270K |
| GILDGILEAD SCIENCES, INC. | 1,703 | $237K |
| CORCencora Inc. | 734 | $231K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.